Established treatments for acute ischaemic stroke

Lancet

Volumn 369, Issue 9558, 2007, Pages 319-330

  Khaja, Aslam M ^a   Grotta, James C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTITHROMBOCYTIC AGENT; CAPTOPRIL; CLONIDINE; CLOPIDOGREL; CORTICOSTEROID; FIBRINOLYTIC AGENT; FUROSEMIDE; GLUCOSE; HEPARIN; HEPARINOID; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; MANNITOL; NICARDIPINE; NITROPRUSSIDE SODIUM; STEROID; URAPIDIL;

ACCIDENT; ALTERNATIVE MEDICINE; ANGIONEUROTIC EDEMA; BLEEDING; BLOOD CLOT LYSIS; BLOOD PRESSURE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN HERNIA; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS; DECUBITUS; DEEP VEIN THROMBOSIS; EMERGENCY WARD; EPILEPTIC STATE; FEVER; GASTROINTESTINAL HEMORRHAGE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HOSPITAL INFECTION; HUMAN; HYPERTENSION; HYPOTENSION; LABORATORY TEST; LUNG EMBOLISM; MEDICAL CARE; MEDICAL LITERATURE; MONOTHERAPY; NEUROIMAGING; OXYGENATION; PATIENT MONITORING; PETECHIA; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SEIZURE; TRANSIENT ISCHEMIC ATTACK; URINARY TRACT INFECTION;

EID: 33846442793     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60154-8     Document Type: Review

References (221)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med 333 (1995) 1581-1587
2. Adams H., Adams R., Del Zoppo G., and Goldstein L. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 36 (2005) 916-923
3. Adams Jr. H., Adams R., Brott T., et al. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 34 (2003) 1056-1083
4. EUSI writing committee. European Stroke Initiative recommendations for stroke management: update 2003. Cerebrovasc Dis 16 (2003) 311-337
5. Wojner-Alexandrov A., Alexandrov A., Rodriguez D., Persse D., and Grotta J. Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke 36 (2005) 1512-1518
6. von Arbin M., Britton M., de Faire U., Helmers C., Miah K., and Murray V. Validation of admission criteria to a stroke unit. J Chronic Dis 33 (1980) 215-220
7. von Arbin M., Britton M., de Faire U., Helmers C., Miah K., and Murray V. Accuracy of bedside diagnosis in stroke. Stroke 12 (1981) 288-293
8. Adams Jr. H., Brott T., Furlan A., et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 94 (1996) 1167-1174
9. Oppenheimer S., and Hachinski V. The cardiac consequences of stroke. Neurol Clin 10 (1992) 167-176
10. Oppenheimer S. Neurogenic cardiac effects of cerebrovascular disease. Curr Opin Neurol 7 (1994) 20-24
11. Dimant J., and Grob D. Electrocardiographic changes and myocardial damage in patients with acute cerebrovascular accidents. Stroke 8 (1977) 448-455
12. Lavy S., Yaar I., Melamed E., and Stern S. The effect of acute stroke on cardiac functions as observed in an intensive stroke care unit. Stroke 5 (1974) 775-780
13. Thompson P., and Robinson J. Stroke after acute myocardial infarction: relation to infarct size. BMJ 2 (1978) 457-459
14. Norris J., Froggatt G., and Hachinski V. Cardiac arrhythmias in acute stroke. Stroke 9 (1978) 392-396
15. Mikolich J., Jacobs W., and Fletcher G. Cardiac arrhythmias in patients with acute cerebrovascular accidents. JAMA 246 (1981) 1314-1317
16. Vingerhoets F., Bogousslavsky J., Regli F., and Van Melle G. Atrial fibrillation after acute stroke. Stroke 24 (1993) 26-30
17. Adams Jr. H., Brott T., Crowell R., et al. Guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 90 (1994) 1588-1601
18. Sagar G., Riley P., and Vohrah A. Is admission chest radiography of any clinical value in acute stroke patients?. Clin Radiol 51 (1996) 499-502
19. Brott T., Adams Jr. H., Olinger C., et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20 (1989) 864-870
20. Goldstein L., Bertels C., and Davis J. Interrater reliability of the NIH stroke scale. Arch Neurol 46 (1989) 660-662
21. Adams Jr. H., Davis P., Leira E., et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 53 (1999) 126-131
22. Kwiatkowski T., Libman R., Frankel M., et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med 340 (1999) 1781-1787
23. Muir K., Weir C., Murray G., Povey C., and Lees K. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke 27 (1996) 1817-1820
24. Norris J., and Hachinski V. Misdiagnosis of stroke. Lancet 1 (1982) 328-331
25. Panzer R., Feibel J., Barker W., and Griner P. Predicting the likelihood of hemorrhage in patients with stroke. Arch Intern Med 145 (1985) 1800-1803
26. Jacobs L., Kinkel W., and Heffner Jr. R. Autopsy correlations of computerized tomography: experience with 6,000 CT scans. Neurology 26 (1976) 1111-1118
27. Kucinski T. Unenhanced CT and acute stroke physiology. Neuroimaging Clin N Am 15 (2005) 397-407 xi-xii.
28. Moulin T., Cattin F., Crepin-Leblond T., et al. Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome. Neurology 47 (1996) 366-375
29. von Kummer R., Allen K., Holle R., et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 205 (1997) 327-333
30. Hacke W., Kaste M., Fieschi C., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 274 (1995) 1017-1025
31. Muir K., and Santosh C. Imaging of acute stroke and transient ischaemic attack. J Neurol Neurosurg Psychiatry 76 suppl 3 (2005) iii19-iii28
32. Chalela J., Kidwell C., Nentwich L., et al. Magnetic resonance imaging and computed tomography in the emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 369 (2007) 293-298
33. Warach S., Chien D., Li W., Ronthal M., and Edelman R. Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology 42 (1992) 1717-1723
34. Warach S., Gaa J., Siewert B., Wielopolski P., and Edelman R. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 37 (1995) 231-241
35. Lutsep H., Albers G., DeCrespigny A., Kamat G., Marks M., and Moseley M. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 41 (1997) 574-580
36. Barber P., Darby D., Desmond P., et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 51 (1998) 418-426
37. Barber P., Darby D., Desmond P., et al. Identification of major ischemic change. Diffusion-weighted imaging versus computed tomography. Stroke 30 (1999) 2059-2065
38. Lee L., Kidwell C., Alger J., Starkman S., and Saver J. Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 31 (2000) 1081-1089
39. Lovblad K., Laubach H., Baird A., et al. Clinical experience with diffusion-weighted MR in patients with acute stroke. AJNR Am J Neuroradiol 19 (1998) 1061-1066
40. Ay H., Buonanno F., Rordorf G., et al. Normal diffusion-weighted MRI during stroke-like deficits. Neurology 52 (1999) 1784-1792
41. van Everdingen K., van der Grond J., Kappelle L., Ramos L., and Mali W. Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke 29 (1998) 1783-1790
42. Gonzalez R., Schaefer P., Buonanno F., et al. Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 210 (1999) 155-162
43. Lovblad K., Baird A., Schlaug G., et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 42 (1997) 164-170
44. Tong D., Yenari M., Albers G., O'Brien M., Marks M., and Moseley M. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6·5 hour) ischemic stroke. Neurology 50 (1998) 864-870
45. Kidwell C., Alger J., and Saver J. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 34 (2003) 2729-2735
46. Sobesky J., Zaro Weber O., Lehnhardt F., et al. Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke 36 (2005) 980-985
47. Mezzapesa D., Petruzzellis M., Lucivero V., et al. Multimodal MR examination in acute ischemic stroke. Neuroradiology 48 (2006) 238-246
48. Kidwell C., Saver J., Mattiello J., et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 47 (2000) 462-469
49. Tomanek A., Coutts S., Demchuk A., et al. MR angiography compared to conventional selective angiography in acute stroke. Can J Neurol Sci 33 (2006) 58-62
50. Fiebach J., Schellinger P., Gass A., et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 35 (2004) 502-506
51. Kidwell C., Chalela J., Saver J., et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 292 (2004) 1823-1830
52. Singer O., Sitzer M., du Mesnil de Rochemont R., and Neumann-Haefelin T. Practical limitations of acute stroke MRI due to patient-related problems. Neurology 62 (2004) 1848-1849
53. Hacke W., and Hirschberg M. General Principles in the treatment of acute ishemic stroke. Cerebrovasc Dis 1 (1991) 93-99
54. Bushnell C., Phillips-Bute B., Laskowitz D., Lynch J., Chilukuri V., and Borel C. Survival and outcome after endotracheal intubation for acute stroke. Neurology 52 (1999) 1374-1381
55. Grotta J., Pasteur W., Khwaja G., Hamel T., Fisher M., and Ramirez A. Elective intubation for neurologic deterioration after stroke. Neurology 45 (1995) 640-644
56. Ronning O., and Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke 30 (1999) 2033-2037
57. Treib J., Grauer M., Woessner R., and Morgenthaler M. Treatment of stroke on an intensive stroke unit: a novel concept. Intensive Care Med 26 (2000) 1598-1611
58. Azzimondi G., Bassein L., Nonino F., et al. Fever in acute stroke worsens prognosis: a prospective study. Stroke 26 (1995) 2040-2043
59. Reith J., Jorgensen H., Pedersen P., et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 347 (1996) 422-425
60. Ginsberg M., and Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke 29 (1998) 529-534
61. Hajat C., Hajat S., and Sharma P. Effects of poststroke pyrexia on stroke outcome a meta-analysis of studies in patients. Stroke 31 (2000) 410-414
62. Wang Y., Lim L., Levi C., Heller R., and Fisher J. Influence of admission body temperature on stroke mortality. Stroke 31 (2000) 404-409
63. Jorgensen H., Reith J., Nakayama H., Kammersgaard L., Raaschou H., and Olsen T. What determines good recovery in patients with the most severe strokes? The Copenhagen Stroke Study. Stroke 30 (1999) 2008-2012
64. Britton M., de Faire U., Helmers C., Miah K., Ryding C., and Wester P. Arrhythmias in patients with acute cerebrovascular disease. Acta Med Scand 205 (1979) 425-428
65. McDermott M., Lefevre F., Arron M., Martin G., and Biller J. ST segment depression detected by continuous electrocardiography in patients with acute ischemic stroke or transient ischemic attack. Stroke 25 (1994) 1820-1824
66. Chua H., Sen S., Cosgriff R., Gerstenblith G., Beauchamp Jr. N., and Oppenheimer S. Neurogenic ST depression in stroke. Clin Neurol Neurosurg 101 (1999) 44-48
67. Kocan M. Cardiovascular effects of acute stroke. Prog Cardiovasc Nurs 14 (1999) 61-67
68. Kolin A., and Norris J. Myocardial damage from acute cerebral lesions. Stroke 15 (1984) 990-993
69. Myers M., Norris J., Hachinski V., Weingert M., and Sole M. Cardiac sequelae of acute stroke. Stroke 13 (1982) 838-842
70. Bruno A., Biller J., Adams Jr. H., et al. Acute blood glucose level and outcome from ischemic stroke: trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 52 (1999) 280-284
71. Candelise L., Landi G., Orazio E., and Boccardi E. Prognostic significance of hyperglycemia in acute stroke. Arch Neurol 42 (1985) 661-663
72. Davalos A. Potential mechanisms of worsening. Cerebrovasc Dis 7 suppl 5 (1997) 19-24
73. Rordorf G., Cramer S., Efird J., Schwamm L., Buonanno F., and Koroshetz W. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 28 (1997) 2133-2138
74. Walzl M., Schied G., and Walzl B. Effects of ameliorated haemorheology on clinical symptoms in cerebrovascular disease. Atherosclerosis 139 (1998) 385-389
75. Stoll M., Treib J., Seltmann A., Anton H., and Klaus S. Hemodynamics of stroke patients under therapy with low molecular weight hydroxyethyl starch. Neurol Res 20 (1998) 231-234
76. Matthews W., Oxbury J., Grainger K., and Greenhall R. A blind controlled trial of dextran 40 in the treatment of ischaemic stroke. Brain 99 (1976) 193-206
77. Hemodilution in Stroke Study Group. Hypervolemic hemodilution treatment of acute stroke. Results of a randomized multicenter trial using pentastarch. Stroke 20 (1989) 317-323
78. Koller M., Haenny P., Hess K., Weniger D., and Zangger P. Adjusted hypervolemic hemodilution in acute ischemic stroke. Stroke 21 (1990) 1429-1434
79. Strand T. Evaluation of long-term outcome and safety after hemodilution therapy in acute ischemic stroke. Stroke 23 (1992) 657-662
80. Italian Acute Stroke Study Group. Haemodilution in acute stroke: results of the Italian haemodilution trial. Lancet 331 (1988) 318-321
81. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in acute ischemic stroke. Results of subgroup analyses. Stroke 19 (1988) 464-471
82. Powers W. Acute hypertension after stroke: the scientific basis for treatment decisions. Neurology 43 (1993) 461-467
83. Phillips S. Pathophysiology and management of hypertension in acute ischemic stroke. Hypertension 23 (1994) 131-136
84. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 28 (1997) 2109-2118
85. Patel S., Levine S., Tilley B., et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 286 (2001) 2830-2838
86. Larrue V., von Kummer R., del Zoppo G., and Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 28 (1997) 957-960
87. Brott T., Lu M., Kothari R., et al. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke 29 (1998) 1504-1509
88. Barber P., Zhang J., Demchuk A., Hill M., and Buchan A. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 56 (2001) 1015-1020
89. Reeves M., Arora S., Broderick J., et al. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 36 (2005) 1232-1240
90. Saver J. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol 61 (2004) 1066-1070
91. Demaerschalk B., and Yip T. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States. Stroke 36 (2005) 2500-2503
92. Steiner T., Bluhmki E., Kaste M., et al. The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study. Cerebrovasc Dis 8 (1998) 198-203
93. Hacke W., Kaste M., Fieschi C., et al., for the Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 352 (1998) 1245-1251
94. Clark W., Albers G., Madden K., Hamilton S., and for the Thromblytic therapy in acute ischemic stroke study investigators. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Stroke 31 (2000) 811-816
95. Clark W., Wissman S., Albers G., Jhamandas J., Madden K., and Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 282 (1999) 2019-2026
96. Engelter S., Reichhart M., Sekoranja L., et al. Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology 65 (2005) 1795-1798
97. Sylaja P., Cote R., Buchan A., and Hill M. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry 77 (2006) 826-829
98. Tanne D., Kasner S., Demchuk A., et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 105 (2002) 1679-1685
99. van Oostenbrugge R., Hupperts R., and Lodder J. Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre. J Neurol Neurosurg Psychiatry 77 (2006) 375-377
100. Smith E., Abdullah A., Petkovska I., Rosenthal E., Koroshetz W., and Schwamm L. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke 36 (2005) 2497-2499
101. Gonzales N., Albright K., Noser E., et al. "Mild stroke" should not exclude patients from thrombolytic therapy. Stroke 37 (2006) 621
102. Baumann C., Baumgartner R., Gandjour J., von Budingen H., Siegel A., and Georgiadis D. Good outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms. Stroke 37 (2006) 1332-1333
103. Albers G., Bates V., Clark W., Bell R., Verro P., and Hamilton S. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283 (2000) 1145-1150
104. The ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363 (2004) 768-774
105. Saver J. Time is brain-quantified. Stroke 37 (2006) 263-266
106. Kohrmann M., Juttler E., Fiebach J., et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 5 (2006) 661-667
107. Albers G., Thijs V., Wechsler L., et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 60 (2006) 508-517
108. Lisboa R., Jovanovic B., and Alberts M. Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke 33 (2002) 2866-2871
109. Furlan A. Intra-arterial thrombolysis for acute stroke. Cleve Clin J Med 71 suppl 1 (2004) S31-S38
110. Smith W., Sung G., Starkman S., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36 (2005) 1432-1438
111. Gobin Y., Starkman S., Duckwiler G., et al. MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 35 (2004) 2848-2854
112. Lewandowski C., Frankel M., Tomsick T., et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 30 (1999) 2598-2605
113. Ernst R., Pancioli A., Tomsick T., et al. Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke 31 (2000) 2552-2557
114. Hill M., Barber P., Demchuk A., et al. Acute intravenous-intra-arterial revascularization therapy for severe ischemic stroke. Stroke 33 (2002) 279-282
115. Suarez J., Zaidat O., Sunshine J., Tarr R., Selman W., and Landis D. Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 50 (2002) 251-259
116. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 35 (2004) 904-911
117. Adams Jr. H. Emergent use of anticoagulation for treatment of patients with ischemic stroke. Stroke 33 (2002) 856-861
118. Albers G., Amarenco P., Easton J., Sacco R., and Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 119 (2001) 300S-3020
119. Coull B., Williams L., Goldstein L., et al. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke 33 (2002) 1934-1942
120. Coull B., Williams L., Goldstein L., et al. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Neurology 59 (2002) 13-22
121. Sherman D. Antithrombotic and hypofibrinogenetic therapy in acute ischemic stroke: what is the next step?. Cerebrovasc Dis 17 suppl 1 (2004) 138-143
122. Chamorro A., Busse O., Obach V., et al. The rapid anticoagulation prevents ischemic damage study in acute stroke: final results from the writing committee. Cerebrovasc Dis 19 (2005) 402-404
123. Camerlingo M., Salvi P., Belloni G., Gamba T., Cesana B., and Mamoli A. Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions. Stroke 36 (2005) 2415-2420
124. Al-Sadat A., Sunbulli M., and Chaturvedi S. Use of intravenous heparin by North American neurologists: do the data matter?. Stroke 33 (2002) 1574-1577
125. de Bruijn S., and Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 30 (1999) 484-488
126. Norris J. Extracranial arterial dissection: anticoagulation is the treatment of choice: for. Stroke 36 (2005) 2041-2042
127. Selim M., and Caplan L. Carotid Artery Dissection. Curr Treat Options Cardiovasc Med 6 (2004) 249-253
128. Albers G., Amarenco P., Easton J., Sacco R., and Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 483S-512S
129. Einhaupl K., Villringer A., Meister W., et al. Heparin treatment in sinus venous thrombosis. Lancet 338 (1991) 597-600
130. Sacco R., Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37 (2006) 577-617
131. Einhaupl K., Bousser M., de Bruijn S., et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 13 (2006) 553-559
132. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349 (1997) 1569-1581
133. Zheng-Ming C., and CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 349 (1997) 1641-1649
134. Sherman D., Atkinson R., Chippendale T., et al. Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. JAMA 283 (2000) 2395-2403
135. Larrue V., von Kummer R., Muller A., and Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 32 (2001) 438-441
136. Yusuf S., Zhao F., Mehta S., Chrolavicius S., Tognoni G., and Fox K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
137. The Abciximab in Ischemic Stroke Investigators. Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. Stroke 31 (2000) 601-609
138. Abciximab Emergent Stroke Treatment Trial Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial. Stroke 36 (2005) 880-890
139. The AbESTT II Investigators. Abciximab in Emergent Stroke Treatment Trial-II (AbESTT II): Results of a randomized, double-blind, placebo-control Phase 3 Study. Cerebrovasc Dis 21 suppl 4 (2006)
140. Demchuk A., Hill M., Barber P., Silver B., Patel S., and Levine S. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke 36 (2005) 2110-2115
141. Hill M., Lye T., Moss H., et al. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology 60 (2003) 1525-1527
142. Engelter S., Fluri F., Buitrago-Tellez C., et al. Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke. J Neurol 252 (2005) 1167-1170
143. How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke nit Trialists Collaboration. Stroke 28 (1997) 2139-2144
144. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Stroke Unit Trialists' Collaboration. BMJ 314 (1997) 1151-1159
145. Ronning O., and Guldvog B. Stroke unit versus general medical wards, II: neurological deficits and activities of daily living: a quasi-randomized controlled trial. Stroke 29 (1998) 586-590
146. Ronning O., and Guldvog B. Stroke units versus general medical wards, I: twelve- and eighteen-month survival: a randomized, controlled trial. Stroke 29 (1998) 58-62
147. Indredavik B., Bakke F., Slordahl S., Rokseth R., and Haheim L. Stroke unit treatment improves long-term quality of life: a randomized controlled trial. Stroke 29 (1998) 895-899
148. Indredavik B., Bakke F., Slordahl S., Rokseth R., and Haheim L. Stroke unit treatment. 10-year follow-up. Stroke 30 (1999) 1524-1527
149. Stegmayr B., Asplund K., Hulter-Asberg K., et al. Stroke units in their natural habitat: can results of randomized trials be reproduced in routine clinical practice? Riks-Stroke Collaboration. Stroke 30 (1999) 709-714
150. Jorgensen H., Kammersgaard L., Houth J., et al. Who benefits from treatment and rehabilitation in a stroke unit? A community-based study. Stroke 31 (2000) 434-439
151. Jorgensen H., Kammersgaard L., Nakayama H., et al. Treatment and rehabilitation on a stroke unit improves 5-year survival. A community-based study. Stroke 30 (1999) 930-933
152. Alberts M., Hademenos G., Latchaw R., et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 283 (2000) 3102-3109
153. Updated Primary Stroke Center Certification appendix for the disease-specific care manual. Jt Comm Perspect 25 (2005) 3-6
154. Langhorne P. Measures to improve recovery in the acute phase of stroke. Cerebrovasc Dis 9 suppl 5 (1999) 2-5
155. Sandercock P., van den Belt A., Lindley R., and Slattery J. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. J Neurol Neurosurg Psychiatry 56 (1993) 17-25
156. Gubitz G., Counsell C., Sandercock P., and Signorini D. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 2 (2000) CD000024
157. Counsell C., and Sandercock P. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database Syst Rev 4 (2001) CD000119
158. McCarthy S., and Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age Ageing 15 (1986) 84-88
159. McCarthy S., Turner J., Robertson D., Hawkey C., and Macey D. Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet 310 (1977) 800-801
160. Dumas R., Woitinas F., Kutnowski M., et al. A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke. Age Ageing 23 (1994) 512-516
161. Sandset P., Dahl T., Stiris M., Rostad B., Scheel B., and Abildgaard U. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke. Semin Thromb Hemost 16 suppl (1990) 25-33
162. Turpie A., Gent M., Cote R., et al. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. Ann Intern Med 117 (1992) 353-357
163. Levine M., Gent M., Hirsh J., et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 334 (1996) 677-681
164. Gould M., Dembitzer A., Doyle R., Hastie T., and Garber A. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 130 (1999) 800-809
165. Hyers T., Agnelli G., Hull R., et al. Antithrombotic therapy for venous thromboembolic disease. Chest 114 (1998) 561S-5678
166. Collaborative overview of randomised trials of antiplatelet therapy-III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. BMJ 308 (1994) 235-246
167. Pulmonary Embolism Prevention (PEP) trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 355 (2000) 1295-1302
168. Robbins J. The evolution of swallowing neuroanatomy and physiology in humans: a practical perspective. Ann Neurol 46 (1999) 279-280
169. Elmstahl S., Bulow M., Ekberg O., Petersson M., and Tegner H. Treatment of dysphagia improves nutritional conditions in stroke patients. Dysphagia 14 (1999) 61-66
170. Daniels S., Brailey K., and Foundas A. Lingual discoordination and dysphagia following acute stroke: analyses of lesion localization. Dysphagia 14 (1999) 85-92
171. Addington W., Stephens R., Gilliland K., and Rodriguez M. Assessing the laryngeal cough reflex and the risk of developing pneumonia after stroke. Arch Phys Med Rehabil 80 (1999) 150-154
172. Addington W., Stephens R., and Gilliland K. Assessing the laryngeal cough reflex and the risk of developing pneumonia after stroke: an interhospital comparison. Stroke 30 (1999) 1203-1207
173. DePippo K., Holas M., and Reding M. Validation of the 3-oz water swallow test for aspiration following stroke. Arch Neurol 49 (1992) 1259-1261
174. The FOOD Trial Collaboration. Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet 365 (2005) 764-772
175. Nakagawa T., Sekizawa K., Arai H., Kikuchi R., Manabe K., and Sasaki H. High incidence of pneumonia in elderly patients with basal ganglia infarction. Arch Intern Med 157 (1997) 321-324
176. Ween J., Alexander M., D'Esposito M., and Roberts M. Incontinence after stroke in a rehabilitation setting: outcome associations and predictive factors. Neurology 47 (1996) 659-663
177. Chamorro A., Horcajada J., Obach V., et al. The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke 36 (2005) 1495-1500
178. Davalos A., and Castillo J. Potential Mechanisms of Worsening. Cerebrovasc Dis 7 suppl 5 (1997) 19-24
179. Castillo J. Deteriorating stroke: diagnostic criteria, predictors, mechanisms and treatment. Cerebrovasc Dis 9 suppl 3 (1999) 1-8
180. Yamamoto H., Bogousslavsky J., and van Melle G. Different predictors of neurological worsening in different causes of stroke. Arch Neurol 55 (1998) 481-486
181. Roden-Jullig A. Progressing Stroke: Epidemiology. Cerebrovasc Dis 7 suppl 5 (1997) 2-5
182. The Ancrod Stroke Study Investigators. Ancrod for the treatment of acute ischemic brain infarction. Stroke 25 (1994) 1755-1759
183. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The
184. Bogousslavsky J., and Regli F. Anticoagulant-induced intracerebral bleeding in brain ischemia. Evaluation in 200 patients with TIAs, emboli from the heart, and progressing stroke. Acta Neurol Scand 71 (1985) 464-471
185. Bladin C., Alexandrov A., Bellavance A., et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 57 (2000) 1617-1622
186. van der Worp H., and Kappelle L. Complications of acute ischaemic stroke. Cerebrovasc Dis 8 (1998) 124-132
187. Kilpatrick C., Davis S., Hopper J., and Rossiter S. Early seizures after acute stroke. Risk of late seizures. Arch Neurol 49 (1992) 509-511
188. Kilpatrick C., Davis S., Tress B., Rossiter S., Hopper J., and Vandendriesen M. Epileptic seizures in acute stroke. Arch Neurol 47 (1990) 157-160
189. Awada A., Omojola M., and Obeid T. Late epileptic seizures after cerebral infarction. Acta Neurol Scand 99 (1999) 265-268
190. Burn J., Dennis M., Bamford J., Sandercock P., Wade D., and Warlow C. Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ 315 (1997) 1582-1587
191. Rumbach L., Sablot D., Berger E., Tatu L., Vuillier F., and Moulin T. Status epilepticus in stroke: report on a hospital-based stroke cohort. Neurology 54 (2000) 350-354
192. Kappelle L., and Van Der Worp H. Treatment or prevention of complications of acute ischemic stroke. Curr Neurol Neurosci Rep 4 (2004) 36-41
193. Plum F. Brain swelling and edema in cerebral vascular disease. Res Publ Assoc Res Nerv Ment Dis 41 (1966) 318-348
194. Wijdicks E., and Diringer M. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin Proc 73 (1998) 829-836
195. Hacke W., Schwab S., Horn M., Spranger M., De Georgia M., and von Kummer R. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 53 (1996) 309-315
196. Heinsius T., Bogousslavsky J., and Van Melle G. Large infarcts in the middle cerebral artery territory. Etiology and outcome patterns. Neurology 50 (1998) 341-350
197. Berrouschot J., Sterker M., Bettin S., Koster J., and Schneider D. Mortality of space-occupying ('malignant') middle cerebral artery infarction under conservative intensive care. Intensive Care Med 24 (1998) 620-623
198. Ropper A., and Shafran B. Brain edema after stroke. Clinical syndrome and intracranial pressure. Arch Neurol 41 (1984) 26-29
199. Tinker J., and Michenfelder J. Sodium nitroprusside: pharmacology, toxicology and therapeutics. Anesthesiology 45 (1976) 340-354
200. Marsh M., Marshall L., and Shapiro H. Neurosurgical intensive care. Anesthesiology 47 (1977) 149-163
201. Gujjar A., Deibert E., Manno E., Duff S., and Diringer M. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology 51 (1998) 447-451
202. Crockard H., Coppel D., and Morrow W. Evaluation of hyperventilation in treatment of head injuries. BMJ 4 (1973) 634-640
203. Schwab S., Aschoff A., Spranger M., Albert F., and Hacke W. The value of intracranial pressure monitoring in acute hemispheric stroke. Neurology 47 (1996) 393-398
204. Bauer R., and Tellez H. Dexamethasone as treatment in cerebrovascular disease. 2. A controlled study in acute cerebral infarction. Stroke 4 (1973) 547-555
205. Norris J. Steroid therapy in acute cerebral infarction. Arch Neurol 33 (1976) 69-71
206. Norris J., and Hachinski V. High dose steroid treatment in cerebral infarction. BMJ 292 (1986) 21-23
207. Manno E., Adams R., Derdeyn C., Powers W., and Diringer M. The effects of mannitol on cerebral edema after large hemispheric cerebral infarct. Neurology 52 (1999) 583-587
208. Marshall L., Smith R., Rauscher L., and Shapiro H. Mannitol dose requirements in brain-injured patients. J Neurosurg 48 (1978) 169-172
209. Delashaw J., Broaddus W., Kassell N., et al. Treatment of right hemispheric cerebral infarction by hemicraniectomy. Stroke 21 (1990) 874-881
210. Kalia K., and Yonas H. An aggressive approach to massive middle cerebral artery infarction. Arch Neurol 50 (1993) 1293-1297
211. Kondziolka D., and Fazl M. Functional recovery after decompressive craniectomy for cerebral infarction. Neurosurgery 23 (1988) 143-147
212. Steiger H. Outcome of acute supratentorial cerebral infarction in patients under 60. Development of a prognostic grading system. Acta Neurochir (Wien) 111 (1991) 73-79
213. Rieke K., Schwab S., Krieger D., et al. Decompressive surgery in space-occupying hemispheric infarction: results of an open, prospective trial. Crit Care Med 23 (1995) 1576-1587
214. Carter B., Ogilvy C., Candia G., Rosas H., and Buonanno F. One-year outcome after decompressive surgery for massive nondominant hemispheric infarction. Neurosurgery 40 (1997) 1168-1175
215. Schwab S., Steiner T., Aschoff A., et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 29 (1998) 1888-1893
216. Sakai K., Iwahashi K., Terada K., Gohda Y., Sakurai M., and Matsumoto Y. Outcome after external decompression for massive cerebral infarction. Neurol Med Chir (Tokyo) 38 (1998) 131-135
217. Koh M., Goh K., Tung M., and Chan C. Is decompressive craniectomy for acute cerebral infarction of any benefit?. Surg Neurol 53 (2000) 225-230
218. Uhl E., Kreth F., Elias B., et al. Outcome and prognostic factors of hemicraniectomy for space occupying cerebral infarction. J Neurol Neurosurg Psychiatry 75 (2004) 270-274
219. Ogasawara K., Koshu K., Nagamine Y., Fujiwara S., Mizoi K., and Yoshimoto T. [Surgical decompression for massive cerebellar infarction]. No Shinkei Geka 23 (1995) 43-48
220. Mohsenipour I., Gabl M., Schutzhard E., and Twerdy K. Suboccipital decompressive surgery in cerebellar infarction. Zentralbl Neurochir 60 (1999) 68-73
221. Prat R., Conde F., Febles P., Cortes S., and Millan-Corada A. Space-occupying cerebellar infarcts: surgical or conservative treatment? [in Spanish]. Rev Neurol 38 (2004) 133-136